Market Tracker

07/27 1:19pm ET

Arbutus Biopharma Corp (NASDAQ:ABUS)

4.13
Delayed Data
As of 12:36pm ET
 +0.031 / +0.76%
Today’s Change
2.72
Today|||52-Week Range
11.50
-7.17%
Year-to-Date
No recent news for Arbutus Biopharma Corp.

Today’s Trading

Previous close4.10
Today’s open4.14
Day’s range4.13 - 4.17
Volume18,272
Average volume (3 months)177,568
Market cap$224.0M
Dividend yield--
Data as of 12:36pm ET, 07/27/2016

Growth & Valuation

Earnings growth (last year)+25.56%
Earnings growth (this year)-11.04%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+66.34%
P/E ratio--
Price/Sales8.13
Price/Book0.41

Competitors

 Today’s
change
Today’s
% change
ARLZAralez Pharmaceutica...+0.13+3.71%
SELBSelecta Biosciences ...-0.33-2.61%
FOMXFoamix Pharmaceutica...+0.16+2.21%
MDGNMedgenics Inc-0.02-0.32%
Data as of 1:19pm ET, 07/27/2016

Financials

Next reporting dateAugust 11, 2016
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$24.9M
Annual profit (last year)-$61.1M
Net profit margin-245.73%

Profile

Sector
Health Technology
Industry
Biotechnology
Managing Director
Michael J. Abrams
President, Chief Executive Officer &
Director
Mark J. Murray
Corporate headquarters
Burnaby, British Columbia

Forecasts